Research-use peptides and gray-market GLP-1s: the risks

Vials sold as research chemicals are not medicine, and that label is the seller's legal cover. What you take on, and why dosing is the biggest risk.

There is a corner of the internet selling semaglutide and tirzepatide as powders or vials labelled 'research use only' or 'not for human consumption', at prices far below any clinical service. People buy them, reconstitute them and inject them. It is worth being plain about what that involves, without pretending the appeal is mysterious: it is cheaper, and nobody says no to you.

What does 'research use only' actually mean?

It means the seller is not selling you a medicine. That label is the mechanism by which a product sits outside the rules that govern prescription drugs: no prescription, no pharmacy license, no requirement to meet pharmaceutical standards for identity, purity, sterility or strength, and no accountability to a regulator for what is in the vial. It is not a formality or a loophole that everyone understands to be fictional. It is the actual basis on which the transaction is legal for the seller.

One consequence worth sitting with: if the contents are wrong, there is no recall, no batch record and nobody to answer for it.

What are you taking on?

• Unverified identity and purity. You cannot know what is in it, or what else is in it.
• Unverified strength. Dosing assumes a concentration that nobody has certified.
• No sterility assurance. Injectable preparations have to be made and handled sterile; a research-grade powder is not prepared to that standard, and your kitchen is not a clean room.
• No screening. Nobody has checked the contraindications, your other medications, or whether a GLP-1 is appropriate for you at all.
• No monitoring. If something goes wrong, there is no care team, no record and no prescriber — and you may be reluctant to tell a clinician what you took, which is the worst version of this.

Why is dosing the biggest practical risk?

Because it involves multiple steps where a tenfold error is possible and invisible. A powder has to be reconstituted with a chosen volume of liquid, which sets a concentration. That concentration then has to be converted into a volume to draw up in a syringe marked in units, not milligrams. Each step depends on getting the previous one right, and nothing checks you.

This is not hypothetical: dosing errors with GLP-1s obtained outside the licensed chain have resulted in people taking many times the intended dose and needing emergency care. Units are not milligrams, concentrations differ between products, and a syringe does not convert anything for you.

Isn't a compounded prescription the same thing?

No, and the difference is specific rather than rhetorical. A compounded prescription involves a licensed clinician who reviewed your history and can decline, a licensed pharmacy that prepared the medication under standards and inspection, a label with your name and a stated concentration, a beyond-use date, and someone to contact. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. That is a meaningful gap in assurance compared with an approved product — and a different universe from an anonymous vial.

If you have already taken one

Tell a clinician, and be straightforward about what you took and how much. The instinct to stay quiet about a gray-market purchase is understandable and actively dangerous: dose, timing and contents all change what a clinician should do. For severe abdominal pain, persistent vomiting, signs of dehydration or any emergency, call 911 — and say what you injected.

This article is educational and is not a substitute for personalized medical advice. Whether any medication is appropriate for you is a decision for a licensed clinician who has reviewed your health history.